189 related articles for article (PubMed ID: 32378891)
1. Stalobacin: Discovery of Novel Lipopeptide Antibiotics with Potent Antibacterial Activity against Multidrug-Resistant Bacteria.
Matsui K; Kan Y; Kikuchi J; Matsushima K; Takemura M; Maki H; Kozono I; Ueda T; Minagawa K
J Med Chem; 2020 Jun; 63(11):6090-6095. PubMed ID: 32378891
[TBL] [Abstract][Full Text] [Related]
2. A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics.
Domhan C; Uhl P; Meinhardt A; Zimmermann S; Kleist C; Lindner T; Leotta K; Mier W; Wink M
Int J Antimicrob Agents; 2018 Jul; 52(1):52-62. PubMed ID: 29649587
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial Activity of Telavancin Tested
Duncan LR; Sader HS; Huband MD; Flamm RK; Mendes RE
Microb Drug Resist; 2020 Aug; 26(8):934-943. PubMed ID: 32049591
[TBL] [Abstract][Full Text] [Related]
4. Short cationic lipopeptides as effective antibacterial agents: Design, physicochemical properties and biological evaluation.
Azmi F; Elliott AG; Marasini N; Ramu S; Ziora Z; Kavanagh AM; Blaskovich MA; Cooper MA; Skwarczynski M; Toth I
Bioorg Med Chem; 2016 May; 24(10):2235-41. PubMed ID: 27048775
[TBL] [Abstract][Full Text] [Related]
5. Potent Antibiotics Active against Multidrug-Resistant Gram-Negative Bacteria.
Otsuka Y
Chem Pharm Bull (Tokyo); 2020; 68(3):182-190. PubMed ID: 32115524
[TBL] [Abstract][Full Text] [Related]
6. New Paenibacillus strain produces a family of linear and cyclic antimicrobial lipopeptides: cyclization is not essential for their antimicrobial activity.
Huang E; Yang X; Zhang L; Moon SH; Yousef AE
FEMS Microbiol Lett; 2017 Apr; 364(8):. PubMed ID: 28333237
[TBL] [Abstract][Full Text] [Related]
7. Discovery, Synthesis, and Optimization of Peptide-Based Antibiotics.
Hanna CC; Hermant YO; Harris PWR; Brimble MA
Acc Chem Res; 2021 Apr; 54(8):1878-1890. PubMed ID: 33750106
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial efficacy and membrane mechanism of action of the
Decker T; Rautenbach M; Khan S; Khan W
Microbiol Spectr; 2024 Jul; 12(7):e0295223. PubMed ID: 38842361
[TBL] [Abstract][Full Text] [Related]
9. A potent antibacterial activity of new short d-enantiomeric lipopeptide against multi drug resistant bacteria.
Lee J; Kim S; Sim JY; Lee D; Kim HH; Hwang JS; Lee DG; Park ZY; Kim JI
Biochim Biophys Acta Biomembr; 2019 Jan; 1861(1):34-42. PubMed ID: 30393205
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationship of novel bisindole amidines active against MDR Gram-positive and Gram-negative bacteria.
Liu Y; Hu X; Wu Y; Zhang W; Chen X; You X; Hu L
Eur J Med Chem; 2018 Apr; 150():771-782. PubMed ID: 29604581
[TBL] [Abstract][Full Text] [Related]
11. Telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2014).
Duncan LR; Sader HS; Smart JI; Flamm RK; Mendes RE
J Glob Antimicrob Resist; 2017 Sep; 10():271-276. PubMed ID: 28735051
[TBL] [Abstract][Full Text] [Related]
12. Membrane-targeting, ultrashort lipopeptide acts as an antibiotic adjuvant and sensitizes MDR gram-negative pathogens toward narrow-spectrum antibiotics.
Panjla A; Kaul G; Shukla M; Akhir A; Tripathi S; Arora A; Chopra S; Verma S
Biomed Pharmacother; 2024 Jul; 176():116810. PubMed ID: 38823276
[TBL] [Abstract][Full Text] [Related]
13. Synergistic antimicrobial activity of combinations of sanguinarine and EDTA with vancomycin against multidrug resistant bacteria.
Hamoud R; Reichling J; Wink M
Drug Metab Lett; 2014; 8(2):119-28. PubMed ID: 25692301
[TBL] [Abstract][Full Text] [Related]
14. In vitro activities of telavancin and six comparator agents against anaerobic bacterial isolates.
Finegold SM; Bolanos M; Sumannen PH; Molitoris DR
Antimicrob Agents Chemother; 2009 Sep; 53(9):3996-4001. PubMed ID: 19581457
[TBL] [Abstract][Full Text] [Related]
15. Self-assembling lipopeptides with a potent activity against Gram-positive bacteria, including multidrug resistant strains.
Azmi F; Elliott AG; Khalil ZG; Hussein WM; Kavanagh A; Huang JX; Quezada M; Blaskovich MA; Capon RJ; Cooper MA; Skwarczynski M; Toth I
Nanomedicine (Lond); 2015 Nov; 10(22):3359-71. PubMed ID: 26909416
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial and biofilm disruptive nonribosomal lipopeptides from Streptomyces parvulus against multidrug-resistant bacterial infections.
Kadaikunnan S; Vijayaragavan P; Rathi MA; Balamuralikrishnan B; Alharbi NS; Gopalakrishnan VK; Purushothaman S; Sivanesan R
J Infect Public Health; 2024 Mar; 17(3):450-456. PubMed ID: 38262082
[TBL] [Abstract][Full Text] [Related]
17. Cyathea gigantea (Cyatheaceae) as an antimicrobial agent against multidrug resistant organisms.
Nath K; Talukdar AD; Bhattacharya MK; Bhowmik D; Chetri S; Choudhury D; Mitra A; Choudhury NA
BMC Complement Altern Med; 2019 Oct; 19(1):279. PubMed ID: 31640666
[TBL] [Abstract][Full Text] [Related]
18. Octapeptins: Lipopeptide Antibiotics against Multidrug-Resistant Superbugs.
Abou Fayad A; Herrmann J; Müller R
Cell Chem Biol; 2018 Apr; 25(4):351-353. PubMed ID: 29677485
[TBL] [Abstract][Full Text] [Related]
19. Dilipid ultrashort cationic lipopeptides as adjuvants for chloramphenicol and other conventional antibiotics against Gram-negative bacteria.
Domalaon R; Brizuela M; Eisner B; Findlay B; Zhanel GG; Schweizer F
Amino Acids; 2019 Mar; 51(3):383-393. PubMed ID: 30392097
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of telavancin compared with vancomycin and linezolid against Gram-positive organisms isolated from cancer patients.
Rolston K; Wang W; Nesher L; Coyle E; Shelburne S; Prince RA
J Antibiot (Tokyo); 2014 Jul; 67(7):505-9. PubMed ID: 24824818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
